Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 65

1.

Diverse Papillomavirus Types Induce Endosomal Tubulation.

Siddiqa A, Massimi P, Pim D, Banks L.

Front Cell Infect Microbiol. 2019 May 28;9:175. doi: 10.3389/fcimb.2019.00175. eCollection 2019.

2.

Choosing the right path: membrane trafficking and infectious entry of small DNA tumor viruses.

Bugnon Valdano M, Pim D, Banks L.

Curr Opin Cell Biol. 2019 Aug;59:112-120. doi: 10.1016/j.ceb.2019.03.013. Epub 2019 May 22. Review.

PMID:
31128386
3.

Phosphorylation of Human Papillomavirus Type 16 L2 Contributes to Efficient Virus Infectious Entry.

Broniarczyk J, Massimi P, Pim D, Bergant Marušič M, Myers MP, Garcea RL, Banks L.

J Virol. 2019 Jun 14;93(13). pii: e00128-19. doi: 10.1128/JVI.00128-19. Print 2019 Jul 1.

4.

Oncogenic comparison of human papillomavirus type 58 E7 variants.

Law PT, Boon SS, Hu C, Lung RW, Cheung GP, Ho WC, Chen Z, Massimi P, Thomas M, Pim D, Banks L, Chan PK.

J Cell Mol Med. 2019 Feb;23(2):1517-1527. doi: 10.1111/jcmm.14059. Epub 2018 Dec 21.

5.

Human Papillomavirus 16 Infection Induces VAP-Dependent Endosomal Tubulation.

Siddiqa A, Massimi P, Pim D, Broniarczyk J, Banks L.

J Virol. 2018 Feb 26;92(6). pii: e01514-17. doi: 10.1128/JVI.01514-17. Print 2018 Mar 15.

6.

Retriever is a multiprotein complex for retromer-independent endosomal cargo recycling.

McNally KE, Faulkner R, Steinberg F, Gallon M, Ghai R, Pim D, Langton P, Pearson N, Danson CM, Nägele H, Morris LL, Singla A, Overlee BL, Heesom KJ, Sessions R, Banks L, Collins BM, Berger I, Billadeau DD, Burstein E, Cullen PJ.

Nat Cell Biol. 2017 Oct;19(10):1214-1225. doi: 10.1038/ncb3610. Epub 2017 Sep 11.

7.

Characterizing the spatio-temporal role of sorting nexin 17 in human papillomavirus trafficking.

Bergant M, Peternel Š, Pim D, Broniarczyk J, Banks L.

J Gen Virol. 2017 Apr;98(4):715-725. doi: 10.1099/jgv.0.000734.

PMID:
28475030
8.

The VPS4 component of the ESCRT machinery plays an essential role in HPV infectious entry and capsid disassembly.

Broniarczyk J, Pim D, Massimi P, Bergant M, Goździcka-Józefiak A, Crump C, Banks L.

Sci Rep. 2017 Mar 28;7:45159. doi: 10.1038/srep45159.

9.

Interaction of the Human Papillomavirus E6 Oncoprotein with Sorting Nexin 27 Modulates Endocytic Cargo Transport Pathways.

Ganti K, Massimi P, Manzo-Merino J, Tomaić V, Pim D, Playford MP, Lizano M, Roberts S, Kranjec C, Doorbar J, Banks L.

PLoS Pathog. 2016 Sep 20;12(9):e1005854. doi: 10.1371/journal.ppat.1005854. eCollection 2016 Sep.

10.

A Novel PDZ Domain Interaction Mediates the Binding between Human Papillomavirus 16 L2 and Sorting Nexin 27 and Modulates Virion Trafficking.

Pim D, Broniarczyk J, Bergant M, Playford MP, Banks L.

J Virol. 2015 Oct;89(20):10145-55. doi: 10.1128/JVI.01499-15. Epub 2015 Jul 22.

11.

The Human Papillomavirus E6 PDZ Binding Motif: From Life Cycle to Malignancy.

Ganti K, Broniarczyk J, Manoubi W, Massimi P, Mittal S, Pim D, Szalmas A, Thatte J, Thomas M, Tomaić V, Banks L.

Viruses. 2015 Jul 2;7(7):3530-51. doi: 10.3390/v7072785. Review.

12.

Interaction of HPV E6 oncoproteins with specific proteasomal subunits.

Tomaić V, Ganti K, Pim D, Bauer C, Blattner C, Banks L.

Virology. 2013 Nov;446(1-2):389-96. doi: 10.1016/j.virol.2013.08.016. Epub 2013 Sep 17.

13.

Interactions between E6AP and E6 proteins from alpha and beta HPV types.

Thomas M, Tomaić V, Pim D, Myers MP, Tommasino M, Banks L.

Virology. 2013 Jan 20;435(2):357-62. doi: 10.1016/j.virol.2012.11.004. Epub 2012 Dec 1.

14.

Human tumour viruses and the deregulation of cell polarity in cancer.

Banks L, Pim D, Thomas M.

Nat Rev Cancer. 2012 Dec;12(12):877-86. doi: 10.1038/nrc3400. Review.

PMID:
23175122
15.

Geographical distribution and oncogenic risk association of human papillomavirus type 58 E6 and E7 sequence variations.

Chan PK, Zhang C, Park JS, Smith-McCune KK, Palefsky JM, Giovannelli L, Coutlée F, Hibbitts S, Konno R, Settheetham-Ishida W, Chu TY, Ferrera A, Alejandra Picconi M, De Marco F, Woo YL, Raiol T, Piña-Sánchez P, Bae JH, Wong MC, Chirenje MZ, Magure T, Moscicki AB, Fiander AN, Capra G, Young Ki E, Tan Y, Chen Z, Burk RD, Chan MC, Cheung TH, Pim D, Banks L.

Int J Cancer. 2013 Jun 1;132(11):2528-36. doi: 10.1002/ijc.27932. Epub 2012 Nov 29.

16.

Human papillomaviruses and the specificity of PDZ domain targeting.

Pim D, Bergant M, Boon SS, Ganti K, Kranjec C, Massimi P, Subbaiah VK, Thomas M, Tomaić V, Banks L.

FEBS J. 2012 Oct;279(19):3530-3537. doi: 10.1111/j.1742-4658.2012.08709.x. Epub 2012 Aug 29. Review.

17.

HPV-16 E2 contributes to induction of HPV-16 late gene expression by inhibiting early polyadenylation.

Johansson C, Somberg M, Li X, Backström Winquist E, Fay J, Ryan F, Pim D, Banks L, Schwartz S.

EMBO J. 2012 May 22;31(14):3212-27. doi: 10.1038/emboj.2012.147.

18.

The mechanism and implications of hScrib regulation of ERK.

Nagasaka K, Massimi P, Pim D, Subbaiah VK, Kranjec C, Nakagawa S, Yano T, Taketani Y, Banks L.

Small GTPases. 2010 Sep;1(2):108-112.

19.

Identification of human papillomavirus type 58 lineages and the distribution worldwide.

Chan PK, Luk AC, Park JS, Smith-McCune KK, Palefsky JM, Konno R, Giovannelli L, Coutlée F, Hibbitts S, Chu TY, Settheetham-Ishida W, Picconi MA, Ferrera A, De Marco F, Woo YL, Raiol T, Piña-Sánchez P, Cheung JL, Bae JH, Chirenje MZ, Magure T, Moscicki AB, Fiander AN, Di Stefano R, Cheung TH, Yu MM, Tsui SK, Pim D, Banks L.

J Infect Dis. 2011 Jun 1;203(11):1565-73. doi: 10.1093/infdis/jir157.

20.

Retinoblastoma-independent antiproliferative activity of novel intracellular antibodies against the E7 oncoprotein in HPV 16-positive cells.

Accardi L, Donà MG, Mileo AM, Paggi MG, Federico A, Torreri P, Petrucci TC, Accardi R, Pim D, Tommasino M, Banks L, Chirullo B, Giorgi C.

BMC Cancer. 2011 Jan 17;11:17. doi: 10.1186/1471-2407-11-17.

21.

Regulation of the human papillomavirus type 18 E6/E6AP ubiquitin ligase complex by the HECT domain-containing protein EDD.

Tomaic V, Pim D, Thomas M, Massimi P, Myers MP, Banks L.

J Virol. 2011 Apr;85(7):3120-7. doi: 10.1128/JVI.02004-10. Epub 2011 Jan 12.

22.

The cell polarity regulator hScrib controls ERK activation through a KIM site-dependent interaction.

Nagasaka K, Pim D, Massimi P, Thomas M, Tomaić V, Subbaiah VK, Kranjec C, Nakagawa S, Yano T, Taketani Y, Myers M, Banks L.

Oncogene. 2010 Sep 23;29(38):5311-21. doi: 10.1038/onc.2010.265. Epub 2010 Jul 12.

PMID:
20622900
23.

Interaction of viral oncoproteins with cellular target molecules: infection with high-risk vs low-risk human papillomaviruses.

Pim D, Banks L.

APMIS. 2010 Jun;118(6-7):471-93. doi: 10.1111/j.1600-0463.2010.02618.x. Review.

PMID:
20553529
24.

The stability of the human papillomavirus E6 oncoprotein is E6AP dependent.

Tomaić V, Pim D, Banks L.

Virology. 2009 Oct 10;393(1):7-10. doi: 10.1016/j.virol.2009.07.029. Epub 2009 Aug 22.

25.
26.

Human papillomaviruses, cervical cancer and cell polarity.

Thomas M, Narayan N, Pim D, Tomaić V, Massimi P, Nagasaka K, Kranjec C, Gammoh N, Banks L.

Oncogene. 2008 Nov 24;27(55):7018-30. doi: 10.1038/onc.2008.351. Review.

PMID:
19029942
27.
28.

HPV-18 E6*I modulates HPV-18 full-length E6 functions in a cell cycle dependent manner.

Guccione E, Pim D, Banks L.

Int J Cancer. 2004 Jul 20;110(6):928-33.

29.
30.

Viruses and the 26S proteasome: hacking into destruction.

Banks L, Pim D, Thomas M.

Trends Biochem Sci. 2003 Aug;28(8):452-9.

PMID:
12932734
31.
32.

Regulation of the human papillomavirus oncoproteins by differential phosphorylation.

Massimi P, Pim D, Kühne C, Banks L.

Mol Cell Biochem. 2001 Nov;227(1-2):137-44.

PMID:
11827165
33.
34.

Allosteric activation of acid alpha-glucosidase by the human papillomavirus E7 protein.

Zwerschke W, Mannhardt B, Massimi P, Nauenburg S, Pim D, Nickel W, Banks L, Reuser AJ, Jansen-Dürr P.

J Biol Chem. 2000 Mar 31;275(13):9534-41.

35.

HPV E6 targeted degradation of the discs large protein: evidence for the involvement of a novel ubiquitin ligase.

Pim D, Thomas M, Javier R, Gardiol D, Banks L.

Oncogene. 2000 Feb 10;19(6):719-25.

36.

Interaction between the HPV-16 E2 transcriptional activator and p53.

Massimi P, Pim D, Bertoli C, Bouvard V, Banks L.

Oncogene. 1999 Dec 16;18(54):7748-54.

37.

The role of the E6-p53 interaction in the molecular pathogenesis of HPV.

Thomas M, Pim D, Banks L.

Oncogene. 1999 Dec 13;18(53):7690-700. Review.

38.
39.

Two polymorphic variants of wild-type p53 differ biochemically and biologically.

Thomas M, Kalita A, Labrecque S, Pim D, Banks L, Matlashewski G.

Mol Cell Biol. 1999 Feb;19(2):1092-100.

42.
43.
46.

DNA damage induced p53 mediated transcription is inhibited by human papillomavirus type 18 E6.

Gu Z, Pim D, Labrecque S, Banks L, Matlashewski G.

Oncogene. 1994 Feb;9(2):629-33.

PMID:
8290274
47.

Lack of immortalizing activity of a human papillomavirus type 16 variant DNA with a mutation in the E2 gene isolated from normal human cervical keratinocytes.

Storey A, Greenfield I, Banks L, Pim D, Crook T, Crawford L, Stanley M.

Oncogene. 1992 Mar;7(3):459-65.

PMID:
1312701
48.
50.

Supplemental Content

Support Center